Reuters
CHICAGO, July 20 (Reuters) – Scientists are working on a benchmark for COVID-19 vaccine efficacy that would allow drugmakers to conduct smaller, speedier human trials to get them to market and address a huge global vaccine shortage.
READ FULL ARTICLE HERE > https://www.reuters.com/business/healthcare-pharmaceuticals/global-quest-underway-speed-covid-19-vaccine-trials-2021-07-20/